A detailed history of Private Capital Group, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 633 shares of AXSM stock, worth $59,881. This represents 0.02% of its overall portfolio holdings.

Number of Shares
633
Previous 529 19.66%
Holding current value
$59,881
Previous $22,000 9.09%
% of portfolio
0.02%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

BUY
$21.74 - $46.75 $2,260 - $4,862
104 Added 19.66%
633 $24,000
Q1 2022

Apr 21, 2022

BUY
$23.7 - $41.39 $876 - $1,531
37 Added 7.52%
529 $22,000
Q4 2021

Jan 24, 2022

BUY
$30.7 - $43.36 $1,442 - $2,037
47 Added 10.56%
492 $19,000
Q3 2021

Oct 13, 2021

SELL
$19.91 - $68.26 $6,012 - $20,614
-302 Reduced 40.43%
445 $15,000
Q2 2021

Jul 26, 2021

BUY
$50.63 - $73.5 $11,898 - $17,272
235 Added 45.9%
747 $50,000
Q1 2021

Apr 12, 2021

BUY
$55.91 - $81.44 $28,625 - $41,697
512 New
512 $29,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.06B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.